Weight control and diet

• Highlights
• Introduction
• Biological and Medical Caus...
• Cultural and Emotional Caus...
• Risk Factors
• Complications
• Weight Loss and Maintenance...
• Weight Management
• Medications
• Other Treatments
• Resources
• References

• Cancer prevention guidelines from the American Cancer Society stress the importance of maintaining a healthy weight throughout life. A healthy weight is even more important than eating specific healthy foods, when it comes to cancer prevention.

• The US Food and Drug Administration (FDA) is warning consumers not to buy a product known as the "Brazilian diet pill." This product is labeled as a dietary supplement, but contains several chemicals found in powerful prescription drugs. - 1 Comment
  Read More ›

Diabetes diet

• Highlights
• Introduction
• General Dietary Guidelines...
• Major Food Components
• Weight Control for Type 2 D...
• Heart-Healthy Diets
• Diabetic Exchange Lists
• Exercise
• Resources
• References

Heart-healthy diet

• Highlights
• Introduction
• Dietary Changes
• Lifestyle Changes
• Resources
• References

• In 2006, the American Heart Association (AHA) revised its dietary and lifestyle recommendations. The new guidelines specifically recommend limiting daily saturated fat intake to less than 7% and trans fats to less than 1% of total daily calories.
• The AHA recommends consuming plenty of deep-colored vegetables and fruits, eating oily fish at least twice a week, and including whole grains in your daily diet.

• Women with existing heart disease may consider taking fish oil supplements, suggests 2007 AHA guidelines. Women should include a variety of low-mercury fish in their diet. - 3 Comments
  Read More ›

Obesity

• Signs and Symptoms
• What Causes It?
• Risk Factors
• Preventive Care
• What to Expect at Your Provider's Office
• Treatment Options
• Other Considerations
• Supporting Research

Breast cancer

• Highlights
• Introduction
• Risk Factors
• Prevention and Lifestyle Fa...
• Symptoms
• Diagnosis
• Prognosis
• Treatment
• Surgery
• Radiation
• Medications
• Chemotherapy
• Hormone Therapy
• Resources
• References

• In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
• In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
• In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.

• The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40. - 0 Comments
  Read More ›

Diabetes - type 2

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Screening Tests
• Treatment
• Lifestyle Changes
• Medications
• Long-Term Complications
• Emergency Complications
• Resources
• References

• Sitagliptin (Januvia), the first in a new class of diabetes drugs called DPP-4 inhibitors, was approved in 2006.
• Janumet, a 2-in-1 pill that contains both sitagliptin and metformin, was approved in 2007.
• These drugs are taken by mouth and may be more convenient for patients than exenatide (Byetta), a similar drug. DPP-4 inhibitors do not cause weight gain and may pose a lower risk for hypoglycemia than some other diabetes drugs.

Ulcerative colitis

• Highlights
• Introduction
• Causes
• Symptoms
• Complications
• Risk Factors
• Diagnosis
• Dietary Factors
• Symptom Management
• Medications
• Surgery
• Resources
• References

Crohn's disease

• Highlights
• Introduction
• Causes
• Symptoms
• Complications
• Risk Factors
• Diagnosis
• Dietary Factors
• Symptom Management
• Medications
• Surgery
• Resources
• References

• In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
• As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies. - 0 Comments
  Read More ›

Skin wrinkles and blemishes

• Highlights
• Introduction
• Blemishes
• Risk Factors
• Prevention
• Treatment
• Resurfacing Treatments
• Implant Procedures
• Plastic Surgery
• Resources
• References

• The skin of smokers ages more rapidly than the skin of non-smokers, even in areas of the body not exposed to sunlight, according to a 2007 study. Women in the study who smoked also had much lower levels of vitamin E secretions in their skin. Vitamin E may protect the skin from sun damage.
• There may be an association between smoking and higher frequency of a type of acne (noninflammatory acne) in adult women, according to a European study.

• A study in the Journal of Nutrition found that a combination of antioxidants and trace elements supplementation raises the risk of skin cancer in women, but not in men.

• Overall, exposure to ultraviolet radiation from sunlight (radiation referred to as UVA or UVB) accounts for about 90% of the symptoms of premature skin aging.
• UVB primarily affects the outer skin layers. - 0 Comments
  Read More ›